Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,113,055
-
Share change
-
+338,884
-
Total reported value
-
$176,746,714
-
Price per share
-
$42.97
-
Number of holders
-
94
-
Value change
-
+$14,536,094
-
Number of buys
-
49
-
Number of sells
-
31
Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q4 2015
As of 31 Dec 2015,
BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,113,055 shares.
The largest 10 holders included
Abdiel Capital Advisors, LP, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, RK Capital Management, LLC, Allianz Asset Management AG, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., and WELLS FARGO & COMPANY/MN.
This page lists
94
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.